The DOI matches its Crossref record; 14 of the 15 references it cites were found in a registry or an index.
Effectiveness of Prenatal Versus Postpartum Tetanus, Diphtheria, and Acellular Pertussis Vaccination in Preventing Infant Pertussis
Open accessAbstract
BACKGROUND: Most severe and fatal cases of pertussis occur in infants <8 weeks of age, before initiation of the primary pertussis vaccine series. Women are recommended to receive tetanus, diphtheria, and acellular pertussis (Tdap) vaccine at the start of the third trimester of each pregnancy to optimize transplacental transfer of antibodies to the fetus. This recommendation was made by the Advisory Committee for Immunization Practices based on immunogenicity data, and no studies in the United States have yet evaluated the effectiveness of this strategy in reducing pertussis incidence in infants. METHODS: We evaluated a cohort of mothers with documented Tdap vaccination histories in the California Immunization Registry to determine whether infants whose mothers received Tdap vaccine at 27-36 weeks gestation had a lower risk of pertussis at <8 weeks of age than infants born to women who received Tdap vaccine within 14 days post partum. RESULTS: Tdap vaccination received at 27-36 weeks gestation was found to be 85% (95% confidence interval, 33%-98%) more effective than postpartum Tdap vaccination at preventing pertussis in infants <8 weeks of age . Vaccination at 27-36 weeks gestation was more effective at preventing pertussis in infant than vaccination during the second trimester. CONCLUSIONS: Tdap vaccination at 27-36 weeks gestation was 85% more effective than postpartum vaccination at preventing pertussis in infants <8 weeks of age. Efforts should be made by prenatal care providers to provide Tdap vaccine to pregnant women during routine prenatal visits at the earliest opportunity between 27 and 36 weeks gestation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Maternal vaccination with a pertussis-containing vaccine is now routinely recommended in several countries and has been shown to be safe and to result in high concentrations of antibody in the infant over the first 2 months of life (18–21).”
From Factors Affecting the FcRn-Mediated Transplacental Transfer of Antibodies and Implications for Vaccination in Pregnancy (2017) · cites this paper as [20]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effectiveness of maternal pertussis vaccination in England: an observational study
Amirthalingam, G., Andrews, N., Campbell, H., Ribeiro, S., Kara, E., Donegan, K., Fry, N. K., Miller, E., & Ramsay, M. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60686-3 · Cited by 739
Sawyer, M., Liang, J. L., Messonnier, N. E., & Clark, T. A. (2013) · PubMed Central · Cited by 582
Field evaluation of vaccine efficacy.
Orenstein, W. A., Bernier, R. H., Tj, D., Hinman, A. R., Js, M., Bart, K. J., & Sirotkin, B. (1985) · Europe PMC (PubMed Central) · Cited by 549
Dabrera, G., Amirthalingam, G., Andrews, N., Campbell, H., Ribeiro, S., Kara, E., Fry, N. K., & Ramsay, M. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/ciu821 · Cited by 385
Eberhardt, C. S., Rohner, G. B., Lemaître, B., Boukrid, M., Combescure, C., Othenin‐Girard, V., Chilin, A., Pétré, J., de Tejada, B. M., & Siegrist, C. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw027 · Cited by 256
Natural History of Pertussis Antibody in the Infant and Effect on Vaccine Response
Savage, J. V., Decker, M. D., Edwards, K. M., SELL, S. H. W., & Karzon, D. T. (1990) · The Journal of Infectious Diseases · doi:10.1093/infdis/161.3.487 · Cited by 208
Healy, C. M., Rench, M. A., & Baker, C. J. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis923 · Cited by 193
Risk Factors Associated With Infant Deaths From Pertussis: A Case-Control Study
Winter, K., Zipprich, J., Harriman, K. H., Murray, E. L., GORNBEIN, J. A., Hammer, S. J., Yeganeh, N., Adachi, K., & Cherry, J. D. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ472 · Cited by 185
Self-citationHalperin, B. A., Morris, A., MacKinnon‐Cameron, D., Mutch, J., Langley, J. M., McNeil, S., MacDougall, D., & Halperin, S. A. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir538 · Cited by 163
Sources of Infant Pertussis Infection in the United States
Skoff, T. H., Kenyon, C., Cocoros, N. M., Liko, J., Miller, L. A., Kudish, K. S., Baumbach, J., Zansky, S. M., Faulkner, A., & Martin, S. W. (2015) · PEDIATRICS · doi:10.1542/peds.2015-1120 · Cited by 153
The influence of maternal immunization on infant immune responses
Englund, J. A. (2007) · Journal of Comparative Pathology · doi:10.1016/j.jcpa.2007.04.006 · Cited by 116
Pregnancy Dose Tdap and Postpartum Cocooning to Prevent Infant Pertussis: A Decision Analysis
Terranella, A., Asay, G. R. B., Messonnier, M. L., Clark, T. A., & Liang, J. L. (2013) · PEDIATRICS · doi:10.1542/peds.2012-3144 · Cited by 112
Cherry, J. D. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu823 · Cited by 34
Cherry, J. D. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ700 · Cited by 8
Flagged first, then by citations
1 of the 15 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Centers for Disease Control and Prevention, 2008, Prevention of pertussis, tetanus and diphtheria among pregnant and postpartum women and their infants, MMWR Early Release, 57, 1
Cited by
Sorted by citations
Liang, J. L., Tiwari, T., Moro, P., Messonnier, N. E., Reingold, A., Sawyer, M., & Clark, T. A. (2018) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6702a1 · Cited by 457
Effectiveness of Vaccination During Pregnancy to Prevent Infant Pertussis
Baxter, R. P., Bartlett, J., FIREMAN, B. H., Lewis, E. M., & Klein, N. P. (2017) · PEDIATRICS · doi:10.1542/peds.2016-4091 · Cited by 255
Wilcox, C. R., Holder, B., & Jones, C. E. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01294 · Cited by 200
Skoff, T. H., Blain, A. E., Watt, J. M., Scherzinger, K., McMahon, M., Zansky, S. M., Kudish, K. S., Cieslak, P. R., Lewis, M., Shang, N., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix724 · Cited by 173
Maternal immunization: where are we now and how to move forward?
Vojtek, I., Dieussaert, I., Doherty, T. M., Franck, V., Hanssens, L., Miller, J. M., Bekkat-Berkani, R., Kandeil, W., Prado-Cohrs, D., & Vyse, A. (2018) · Annals of Medicine · doi:10.1080/07853890.2017.1421320 · Cited by 139
Metadata
- Authors
- Winter, K., Nickell, S., Powell, M., & Harriman, K.
- Affiliations
- California Department of Public Health (US)
- Corresponding author
- Winter, Kathleen
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-09-13
- Volume
- 64
- Issue
- 1
- Pages
- 3-8
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2520614282
- Cited by
- 178
- References
- 15
- Citations by year
- 2026: 4 · 2025: 10 · 2024: 10 · 2023: 13 · 2022: 13 · 2021: 32 · 2020: 18 · 2019: 23 · 2018: 28 · 2017: 27
- FWCI
- 26.57
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- California Department of Public Health
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Health Sciences › Medicine › Infectious Diseases › Diphtheria, Corynebacterium, and Tetanus
- Social Sciences › Health › Vaccine Coverage and Hesitancy
- Keywords
- Tdap vaccine, pertussis prevention, infant pertussis, prenatal vaccination, postpartum vaccination, transplacental antibody transfer, maternal immunization, vaccine effectiveness
- MeSH terms
- Adult, California, Female, Humans, Infant, Infant, Newborn, Male, Postnatal Care, Pregnancy, Prenatal Care, Registries, Risk Factors, Time Factors, Vaccination, Whooping Cough, Outcome Assessment, Health Care, Diphtheria-Tetanus-acellular Pertussis Vaccines, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
